Michael Weig

Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry

Oliver Bader, Michael Weig, Liliane Taverne-Ghadwal et al. · Clinical Microbiology and Infection · 2010 · 226 citations

Human Pathogenic Yeasts, Biochemistry, Medicine +8

The Cell Wall of the Human Pathogen <i>Candida glabrata</i> : Differential Incorporation of Novel Adhesin-Like Wall Proteins

Piet W. J. de Groot, Eefje A. Kraneveld, Qing Yin et al. · Eukaryotic Cell · 2008 · 221 citations · Full text

Identification and Characterization of Four Azole-Resistant <i>erg3</i> Mutants of <i>Candida albicans</i>

Claire M. Martel, Josie E. Parker, Oliver Bader et al. · Antimicrobial Agents and Chemotherapy · 2010 · 165 citations · Full text

Total Sterol Fraction, Fungal Cell Biology, Genetics +19

A Clinical Isolate of <i>Candida albicans</i> with Mutations in <i>ERG11</i> (Encoding Sterol 14α-Demethylase) and <i>ERG5</i> (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B

Claire M. Martel, Josie E. Parker, Oliver Bader et al. · Antimicrobial Agents and Chemotherapy · 2010 · 160 citations · Full text

Clinical Isolate, Total Sterol Fraction, Fungal Cell Biology +18

<i>cyp51A</i> -Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany

Oliver Bader, Michael Weig, Utz Reichard et al. · Antimicrobial Agents and Chemotherapy · 2013 · 122 citations · Full text

Drug Resistance Analysis, Antifungal Agent, Health Sciences +15